Skip to search form
Skip to main content
>
Semantic Scholar
Semantic Scholar's Logo
Search
Sign In
Create Free Account
You are currently offline. Some features of the site may not work correctly.
parsalmide
Known as:
5-amino-N-butyl-2-(2-propynyloxy)benzamide
, parsal
National Institutes of Health
Create Alert
Related topics
Related topics
1 relation
Broader (1)
Benzamides
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Pengaruh Tingkat Inflasi dan Pertumbuhan Ekonomi terhadap Penerimaan Pajak Daerah Khususnya Pajak Hiburan di Kota Bandung (Studi Kasus pada Dinas Pendapatan Daerah Kota Bandung)
Fitri Azhari
2015
Corpus ID: 192412819
Penerimaan Pajak Hiburan di Kota Bandung meningkat setiap tahunnya, dalam tujuh tahun terakhir peningkatan terjadi dari tahun…
Expand
2011
2011
Design and Synthesis of Novel Cyclooxygenase‐1 Inhibitors as Analgesics: 5‐Amino‐2‐ethoxy‐N‐(substituted‐phenyl)benzamides
Ryosuke Fukai
,
X. Zheng
,
Kazunori Motoshima
,
A. Tai
,
F. Yazama
,
H. Kakuta
ChemMedChem
2011
Corpus ID: 2646171
We previously found that N‐(4‐aminophenyl)‐4‐trifluoromethylbenzamide (TFAP), a COX‐1 inhibitor, exhibits an analgesic effect…
Expand
2006
2006
In vitro mutagenicity of anti-inflammatory parsalmide analogues PA7, PA10, and PA31 triggered by biotransformation into hydroxy derivatives.
H. Cardoso
,
B. Bicalho
,
+5 authors
G. de Nucci
European journal of medicinal chemistry
2006
Corpus ID: 12378826
In this study, the mutagenicity of the anti-inflammatory parsalmide [5-amino-N-butyl-2-(2-propynyloxy)-benzamide] analogues PA7…
Expand
2001
2001
Synthesis of substituted benzamides as anti-inflammatory agents that inhibit preferentially cyclooxygenase 1 but do not cause gastric damage.
G. Caliendo
,
V. Santagada
,
+8 authors
G. de Nucci
European journal of medicinal chemistry
2001
Corpus ID: 20771246
Parsalmide (5-amino-N-butyl-2-(2-propynyloxy) benzamide) (5a), is a non-steroidal anti-inflammatory drug (NSAID), commercialised…
Expand
1982
1982
The non‐steroidal anti‐inflammatory agent parsalmide prevents aspirin‐induced H+ back diffusion from the gastric lumen of the rat
A. Bianchetti
,
A. Lavezzo
,
P. Carminati
The Journal of pharmacy and pharmacology
1982
Corpus ID: 35381615
parsalmide is a non steroidal anti-inflammatory agent (NSAIA) the pharmacological activity of which has been demonstrated…
Expand
1976
1976
[Parsalmide, a new synthetic substance, in inflammatory and arthrosic arthropathies. Double-blind controlled clinical trial].
S. Menci
,
M. Rossi
,
G. Del Curatolo
,
P. L. Orsucci
Minerva medica
1976
Corpus ID: 46515084
The double-blind, between-patient experimental technique was employed to investigate the anti-inflammatory, antalgic and…
Expand
1976
1976
[Controlled clinical trial of parsalmide in patients with subacute and chronic arthro-neuro-mypathies].
P. Farneti
,
I. Colombo
Minerva medica
1976
Corpus ID: 10252972
Controlled experiments were carried out to compare the anti-inflammatory, analgesic, muscle-relaxing and anxiolytic…
Expand
1976
1976
[Controlled clinical trial of parsalmide, a drug with analgesic and anti-inflammatory activity].
G. Tafner
,
M. Pedrazzoli
,
E. Bajocchi
Minerva medica
1976
Corpus ID: 28496677
A controlled clinical trial of the anti-inflammatory, analgesic, muscle-relaxing and anxiolytic activity of a new compound…
Expand
1976
1976
[Report of a controlled clinical trial of a new synthetic drug, parsalmide, in rheumatic arthropathies (inflammatory and degenerative)].
C. Sanguinetti
,
F. Bonifazi
Minerva medica
1976
Corpus ID: 9623520
The anti-inflammatory, analgesic and tranquillizing activity of a synthetic compound called parsalmide was investigated in…
Expand
1976
1976
[Controlled clinical trial of a new synthetic preparation (parsalmide) in the treatment of inflammatory and degenerative arthro-myopathies].
R. Franchi
Minerva medica
1976
Corpus ID: 38390429
A double-blind, between-patients trial of a new drug (parsalmide) against indomethacin in the relief of inflammation and pain in…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
,
Terms of Service
, and
Dataset License
ACCEPT & CONTINUE